Multifocal signal modulation therapy of cancer: ancient weapon, modern targets - PubMed (original) (raw)

Review

. 2010 Mar;336(1-2):85-95.

doi: 10.1007/s11010-009-0269-0. Epub 2009 Oct 14.

Affiliations

Review

Multifocal signal modulation therapy of cancer: ancient weapon, modern targets

Tanya Das et al. Mol Cell Biochem. 2010 Mar.

Abstract

Although safe in most cases, ancient treatments are ignored because neither their active components nor their molecular targets are well defined. This is not the case, however, with curcumin, a yellow-pigment substance and component of turmeric (Curcuma longa), which was identified more than a century ago. Recently, extensive research has addressed the chemotherapeutic potential of this relatively nontoxic-plant-derived polyphenol. Because most cancers are caused by deregulation of as many as 500 different genes, agents that target multiple gene products are needed for prevention and treatment of cancer. In this regard, curcumin has been reported to have immense potentiality for being used in cancer chemotherapy because of its control over the machineries of cell survival, proliferation, invasion, and angiogenesis. The mechanisms implicated are diverse and appear to involve a combination of cell signaling pathways at multiple levels. This review seeks to summarize the unique multifocal signal modulatory properties of the "ancient weapon," curcumin, which may be exploited for successful clinical cancer prevention.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Clin Cancer Res. 2005 Oct 15;11(20):7490-8 - PubMed
    1. Cancer Lett. 2008 Aug 18;267(1):133-64 - PubMed
    1. Adv Exp Med Biol. 2007;595:173-84 - PubMed
    1. Biochem Pharmacol. 1998 Mar 15;55(6):775-83 - PubMed
    1. Cancer Res. 1995 Jan 15;55(2):259-66 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources